Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
120.99
-0.56 (-0.46%)
Aug 11, 2026, 10:09 AM EDT - Market open

Incyte Market Cap

Incyte has a market cap or net worth of $24.52 billion as of August 11, 2026. Its market cap has increased by 60.20% in one year.

Market Cap
24.52B
Enterprise Value
20.03B
1-Year Change
60.20%
Ranking
Category
Stock Price
$120.99

Chart

Chart

Since December 1, 1998, Incyte's market cap has increased from $887.90M to $24.52B, an increase of 2,661.95%. That is a compound annual growth rate of 12.72%.

History

DateMarket Cap% Change
Aug 11, 202624.52B26.47%
Dec 31, 202519.39B45.73%
Dec 31, 202413.31B-5.44%
Dec 29, 202314.07B-21.25%
Dec 30, 202217.87B10.21%
Dec 31, 202116.21B-14.88%
Dec 31, 202019.05B1.27%
Dec 31, 201918.81B38.99%
Dec 31, 201813.53B-32.29%
Dec 29, 201719.99B5.81%
Dec 30, 201618.89B-6.36%
Dec 31, 201520.17B63.32%
Dec 31, 201412.35B51.41%
Dec 31, 20138.16B274.30%
Dec 31, 20122.18B14.96%
Dec 30, 20111.90B-7.01%
Dec 31, 20102.04B88.80%
Dec 31, 20091.08B193.21%
Dec 31, 2008368.30M-56.50%
Dec 31, 2007846.70M72.90%
Dec 29, 2006489.70M9.92%
Dec 30, 2005445.50M-39.62%
Dec 31, 2004737.80M48.87%
Dec 31, 2003495.60M59.97%
Dec 31, 2002309.80M-76.00%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
BeOne Medicines AG40.82B
Royalty Pharma33.33B
Insmed29.43B
Alnylam Pharmaceuticals29.03B
Roivant Sciences25.84B
Moderna23.88B
BioNTech SE23.31B
Genmab18.37B
Market Cap Rankings